1Other quality system
Determinations of conformance to appropriate written specifica6ons for acceptance are not made and deficient for drug products.
Inspection Record
Ladd Family Pharmacy LLC — FDA 483 Findings
Inspectors Christopher R Czajka · Nancy E ByerlyThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
2Stability and storage
There is no written testing program designed to assess the stability characteristics of drug products.
3Contamination control
The separate or defined areas and control systems necessary to prevent contamination or mix-ups are deficient.
4Equipment and facility
Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
